In the first half of the year, the outpatient prescription market for flu treatment exceeded 10 billion won in four years. As the number of flu patients surged after the end of the Corona 19 pandemic, the flu treatment market, which had disappeared over the past three years, expanded significantly.

According to UBIST, a drug research institute on the 5th, the outpatient prescription amount for influenza (flu) treatment in the first half of last year was recorded at 11.5 billion won. It fell short of 100 million won in the first half of last year but soared more than 200 times in one year.

In the first and second quarters of last year, the flu treatment market size was only 40 million won